Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Viviane Bertrand"'
Autor:
Wenjia Wang, Mickaël Guedj, Viviane Bertrand, Julie Foucquier, Elisabeth Jouve, Daniel Commenges, Cécile Proust-Lima, Niall P Murphy, Olivier Blin, Laurent Magy, Daniel Cohen, Shahram Attarian
Publikováno v:
PLoS ONE, Vol 12, Iss 1, p e0169878 (2017)
The Charcot-Marie-Tooth Neuropathy Score (CMTNS) was developed as a main efficacy endpoint for application in clinical trials of Charcot-Marie-Tooth disease type 1A (CMT1A). However, the sensitivity of the CMTNS for measuring disease severity and pro
Externí odkaz:
https://doaj.org/article/1ed5e395f7894e9c845085b6ded2e1f7
Autor:
Jean-Michel Vallat, Claire Demiot, Laurent Magy, Arnaud Lacour, Laurence Richard, Mathilde Duchesne, Tania Stojkovic, Daniel Cohen, Viviane Bertrand, Serguei Nabirotchkin, Pierre-Marie Gonnaud, Klaus-Armin Nave, Yann Péréon, Shahram Attarian, Aurore Danigo
Publikováno v:
Journal of Neuropathology & Experimental Neurology. 77:274-281
Charcot-Marie-Tooth disease type 1A (CMT1A), the most common form of Charcot-Marie-Tooth diseases, is a demyelinating neuropathy caused by a deletion encompassing the gene coding for PMP22, a myelin protein of the peripheral nervous system. Although
Autor:
Daniel Cohen, Peter Schmidt, Jacques Touchon, Serguei Nabirotchkin, Robert Philippe, Rene Goedkoop, Sophie Auriacombe, Jacques Hugon, Mickaël Guedj, Jean-Marc Orgogozo, Rodolphe Hajj, Viviane Bertrand, Florence Pasquier, Pierre Jean Ousset, Claude Guériot
Publikováno v:
Alzheimer's & Dementia. 14
Autor:
Mickaël Guedj, Wenjia Wang, Laurent Magy, Daniel Commenges, Julie Foucquier, Niall P. Murphy, Cécile Proust-Lima, Olivier Blin, Elisabeth Jouve, Shahram Attarian, Viviane Bertrand, Daniel Cohen
Publikováno v:
PLoS ONE
PLoS ONE, 2017, 12 (1), pp.e0169878. ⟨10.1371/journal.pone.0169878⟩
PLoS ONE, Vol 12, Iss 1, p e0169878 (2017)
PLoS ONE, 2017, 12 (1), pp.e0169878. ⟨10.1371/journal.pone.0169878⟩
PLoS ONE, Vol 12, Iss 1, p e0169878 (2017)
International audience; The Charcot-Marie-Tooth Neuropathy Score (CMTNS) was developed as a main efficacy endpoint for application in clinical trials of Charcot-Marie-Tooth disease type 1A (CMT1A). However, the sensitivity of the CMTNS for measuring
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::33e7171c920b24877a29e11bad4c47d5
https://hal.science/hal-03598218
https://hal.science/hal-03598218
Autor:
Emmanuel Vial, Damien Toulorge, Nathalie Cholet, Yannick Pereira, Rémy Steinschneider, Esther Graudens, Tangui Maurice, Julie Foucquier, Rodolphe Hajj, Ilya Chumakov, Serguei Nabirotchkin, Aude Milet, Daniel Cohen, Catherine Scart-Grès, Aurélie Boucard, Noelle Callizot, Mickaël Guedj, Sory Traoré, Viviane Bertrand
Publikováno v:
Scientific Reports
Scientific Reports, Nature Publishing Group, 2015, 5 (1), ⟨10.1038/srep07608⟩
Scientific Reports, 2015, 5 (1), ⟨10.1038/srep07608⟩
Scientific Reports, Nature Publishing Group, 2015, 5 (1), ⟨10.1038/srep07608⟩
Scientific Reports, 2015, 5 (1), ⟨10.1038/srep07608⟩
Alzheimer disease (AD) represents a major medical problem where mono-therapeutic interventions demonstrated only a limited efficacy so far. We explored the possibility of developing a combinational therapy that might prevent the degradation of neuron
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c97b170dd001135da9749208d50aa097
https://hal.archives-ouvertes.fr/hal-01922611
https://hal.archives-ouvertes.fr/hal-01922611
Autor:
Philippe Lehert, Catherine Scart-Grès, Viviane Bertrand, Mickaël Guedj, Laurent Magy, Daniel Cohen, Jonas Mandel, Shahram Attarian, Joëlle Micallef, Ilya Chumakov
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, 2015
Orphanet Journal of Rare Diseases, BioMed Central, 2015
Orphanet Journal of Rare Diseases, 2015
Orphanet Journal of Rare Diseases, BioMed Central, 2015
International audience; CMT1A is the most common inherited peripheral neuropathy. There is currently no approved treatment. We performed a meta-analysis including four randomized, double-blind, Placebo-controlled clinical trials to assess the disease
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::817d23ba5e029e914eedc9a3779556e0
https://hal-amu.archives-ouvertes.fr/hal-01203428/file/s13023-015-0293-y.pdf
https://hal-amu.archives-ouvertes.fr/hal-01203428/file/s13023-015-0293-y.pdf
Autor:
Yannick Pereira, Julien Laffaire, Gwenaël Primas, Emmanuel Vial, Jonas Mandel, Serguei Nabirotchkin, Aude Milet, Esther Graudens, Mickaël Guedj, Fabrice Glibert, Ilya Chumakov, Julie Foucquier, Michael W. Sereda, Daniel Cohen, Nathalie Cholet, Klaus-Armin Nave, Aurélie Boucard, Rodolphe Hajj, Viviane Bertrand
Publikováno v:
Orphanet Journal of Rare Diseases
Charcot-Marie-Tooth disease type 1A (CMT1A) is the most common inherited sensory and motor peripheral neuropathy. It is caused by PMP22 overexpression which leads to defects of peripheral myelination, loss of long axons, and progressive impairment th
Autor:
Jonas Mandel, Benoît Funalot, Laurent Magy, Odile Dubourg, Arnaud Lacour, Jean-Michel Vallat, Marie-Noëlle Lefebvre, Lamia Boudiaf, Marguerite Preudhomme, Mahmoud Al-Moussawi, Shahram Attarian, Daniel Cohen, Vincent Tiffreau, Pierre-Marie Gonnaud, Mickaël Guedj, Jérôme Franques, Rodolphe Hajj, Philippe Lehert, Jean Pouget, Catherine Scart-Grès, Armelle Magot, Yann Péréon, Ilya Chumakov, Walter Gilbert, Aude Milet, Laura Bossi, Tanya Stojkovic, Serguei Nabirotchkin, Karima Ghorab, Laurène Leclair-Visonneau, Viviane Bertrand, Joëlle Micallef
Publikováno v:
Orphanet Journal of Rare Diseases
Orphanet Journal of Rare Diseases, Vol. 9, no.1, p. 199 (2014)
Orphanet Journal of Rare Diseases, Vol. 9, no.1, p. 199 (2014)
Background Charcot-Marie-Tooth type 1A disease (CMT1A) is a rare orphan inherited neuropathy caused by an autosomal dominant duplication of a gene encoding for the structural myelin protein PMP22, which induces abnormal Schwann cell differentiation a
Publikováno v:
Cancer Genetics and Cytogenetics. 124:47-55
Cytogenetics studies have suggested that short arm deletion in chromosome 1 is involved in triggering colorectal tumor development. To elucidate the role of 1p under-representation in the tumoral process, we investigated by fluorescence in situ hybri
Autor:
Thomas Aparicio, Sylvie Guichard, Isabelle Lochon, Stanislas Chaussade, Viviane Bertrand, Pierre Canal, Rosine Guimbaud, Etienne Chatelut, Caroline Dusseau, Daniel Couturier, Roland Bugat
Publikováno v:
Cancer Chemotherapy and Pharmacology. 45:477-482
Background/Purpose: Dihydropyridmidine dehydrogenase (DPD) is the initial and rate-limiting enzyme in the catabolism of 5-fluorouracil (5FU). Although this catabolism is likely to occur in the liver in humans, there may be a local inactivation in tum